Tratamiento no farmacológico de la diabetes mellitus tipo 2. Cirugía de la obesidad. Nuevas estrategias terapéuticas

Abstract

The incidence and prevalence of type 2 diabetes mellitus (DM2) and obesity are increasing globally and are closely interrelated. Obesity surgery (metabolic surgery) is a valid, effective tool for weight reduction and remission of DM2. This update describes the different surgical techniques in obesity surgery. It also lists the available evidence on the observational studies and clinical trials that have supported recommendations for this intervention in patients with DM2 and obesity. Lastly, emerging treatment strategies related to peptides involved with the incretin effect (GLP-1, GIP, and glucagon) and glucose receptor inhibitors (SGLT) are described.